Image-guided radiotherapy developer ViewRay has completed a private placement offering as part of its alternative public offering last month.
ViewRay has raised total gross proceeds of $29.4 million through the sale of approximately 5.88 million shares of common stock at $5 per share in the public offering and the latest private placement.
Proceeds from the private placement will be used primarily to support the ongoing commercialization of the company's MRIdian MRI-guided radiation therapy system, research and development, and general corporate purposes, including working capital.
